Showing 5 results for Human
Ali Reza Esteghamati, Mehrshad Abbasi, Abbas Yousefizadeh,
Volume 5, Issue 1 (8-2005)
Abstract
Background: The aim of this study was to compare time action profile of regular human Insulin produced by Exir pharmaceutical Co. and Actrapid® HM produced by Novo Nordisk with euglycemic clamp technique for the first time in Iran.
Methods: Euglycemic glucose clamps were performed with two Insulin brands in a single-center, randomized, double-blind, and crossover study on 6 healthy male volunteers. Glucose disposal kinetics including metabolic clearance rate of glucose (MCRg) and metabolic clearance rate of insulin (MCRi) were determined during a 2-h predetermined intravenous Insulin infusion while blood glucose levels were maintained steady using variable continues intravenous glucose infusions based on method of De Fronzo.
Results: There were no differences in glucose kinetics or time action profile with respect to glucose infusion rates (688.4 vs. 664.6 mg/kg per 120min), MCRg (0.63±0.19 vs. 0.62±0.25 ml/kg), and MCRi(110 % vs110%) between Exir and Novo Nordisk regular human Insulin preparations. Serum insulin levels increased and serum C-peptide levels decreased with both exogenous Insulin infusions which were statistically the same for both preparations.
Conclusion: Time action profile and bioavailability of regular human insulin produced by Exir Pharmaceutical Corporation is comparable with commonly used Novo Nordisk preparation demonstrated by 2 hour euglycemic clamp study.
Maryam Bahadori , Leila Kohan, Nosaybeh Jafari ,
Volume 14, Issue 2 (1-2015)
Abstract
Background: obesity is the major health problems affecting communities worldwide and the prevalence is rapidly rising. Obesity as a lifestyle-related factor increases the risk of many diseases. Omentin is a new adipocytokine that is abundantly expressed in visceral fat tissue and its expression levels reversely correlated with obesity. The purpose of this study was to investigate the association between Val109Asp genetic polymorphism of Omentin gene and obesity risk in women. Methods: This case - control study was done on 260 women, including 186 women with BMI<30 as a control group and 74 women with BMI&ge30 with obesity. Omentin genotypes were determined by the use of polymerase chain reaction (PCR) followed by restriction fragment length polymorphism (RFLP). The data were analyzed using the computer software SPSS for windows version17. Results: Genotype frequencies of the Asp/Asp, Asp/Val and Val/Val in the control group were 65.6%, 31.7%, 2.7% and obese patients were 51.4%, 39.2%, 9.5%, respectively. Comparison of genotype frequencies in the two groups showed that women with Val/Val genotype in compare to Asp/Asp had greater risk for complications of obesity (OR: 4.5, 95%CI: 1.3-14.9, P: 0.01). Conclusion: There is significant association between Val109Asp polymorphism in omentin gene and obesity in Iranian women.
Raziyeh Gharib, Ali Khatibi,
Volume 21, Issue 5 (1-2022)
Abstract
Background: Glycation is the non-enzymatic reaction between the carbonyl groups in sugar and free amino groups in proteins. this reaction leads to changes in structure and functions of proteins. Advanced glycation end products (AGEs) is the final stage in this process, which is highly oxidizing and destructive nature, causing many diabetic complications.
Methods: In the present investigation, the effect of fasting upon the glycation process of human Carbonic anhydrase II under physiological conditions (37 °C and pH 7.4) was studied recruiting various techniques including Ultraviolet–visible spectroscopy, fluorescence spectroscopy and CD Spectroscopy. To address this question, different samples of control carbonic anhydrase (without glucose and 3-beta-hydroxybutyrate), carbonic anhydrase with glucose, carbonic anhydrase in the presence of only 3-beta-hydroxybutyrate (BHB) and carbonic anhydrase along with glucose and 3-beta-hydroxybutyrate were incubated for 35 days under physiological conditions.
Results: The results indicate that 3-beta-hydroxybutyrate, which is greatly increased in the body during fasting, functions as an inhibitor of the glycation process and decreases the impacts of glucose binding to the protein and prevents the formation of AGEs and preserve enzyme activity.
Conclusion: Fasting can play an important role in maintaining the health of the body and eliminating the complications of the disease, with a significant increase in the production of 3-beta-hydroxybutyrate as an inhibitor of the glycation process.
Maedeh Emamjomeh, Majid Hassanpourezatti, Atefeh Hosseinali,
Volume 22, Issue 6 (3-2023)
Abstract
Background: In this study, the effect of oral administration of recombinant human interleukin-2 (rhIL-2) on brain NO level and AChE activity in hyperglycemic conditions induced by high-sucrose diet (HSD), as a type-2 diabetes model, was investigated in Drosophila melanogaster.
Methods: In this experimental research, adult fruit flies of both sexes (30 in each group) were divided into the six groups: receiving normal diet (ND); high-sucrose diet (HSD); ND with rhIL-2 at 0.01 and 0.1 ng/ml; and HSD with rhIL-2 at 0.01 and 0.1 ng/ml. Flies were bred on these culture media for three weeks. At the end of the experiments, the brains of the flies were extracted, homogenized, and glucose, NO, and AChE activity levels were measured by the kit.
Results: Glucose level, AChE activity and NO level increased in brain homogenate of HFD flies compared to ND group. The body weight of HSD flies was reduced compared to the ND. Administration of rhIL-2 along with HFD significantly prevented these changes.
Conclusion: These findings suggest that rhIL-2 partially prevents diabetic neuropathy in Drosophila. It seems that the preventive effects of this compound are mediated through mechanisms dependent on nitric oxide and acetylcholinesterase in the brain.
Mehdi Zarei, Javad Nakhzari Khodakheir,
Volume 23, Issue 4 (11-2023)
Abstract
Background: Physical activity and exercise training are known as an integral part of weight management and control in overweight or obese people. The aim of this study was to compare the effect of high intensity interval training (HIIT) and intense resistance training on asprosin and C1q/tumor necrosis factor related protein1 (CTRP1) serum levels in overweight and obese men.
Methods: In this semi-experimental study, 31 overweight and obese men were randomly divided into three groups: HIIT training (n=10), intense resistance training (n=11) and control (n=10). The subjects of the experimental groups performed HIIT exercises and intense resistance exercises three times a week for nine weeks. Before and after the intervention, blood samples were taken to measure the serum concentration of asprosin and CTRP1 from the subjects. Analysis of covariance test was used to analyze the data and the significance level was considered as p_value less than 0.05.
Results: The concentration of asprosin in the HIIT group (p=0.013) and intense resistance training (p=0.042) decreased significantly compared to the control group. No significant difference in CTRP1 concentration was observed between groups. However, the concentration of CTRP1 in the HIIT group decreased significantly in the post-test compared to the pre-test.
Conclusion: HIIT training and resistance training in overweight and obese men led to a decrease in asprosin levels. Considering the changes in asprosin, CTRP1 and other anthropometric indicators and lipid profiles, HIIT training seems to have a better efficiency in overweight and obese men.
